First Time Loading...

Infinity Pharmaceuticals Inc
NASDAQ:INFI

Watchlist Manager
Infinity Pharmaceuticals Inc Logo
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Watchlist
Price: 0.0037 USD
Updated: May 16, 2024

Infinity Pharmaceuticals Inc
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Infinity Pharmaceuticals Inc
Interest Income Expense Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Infinity Pharmaceuticals Inc
NASDAQ:INFI
Interest Income Expense
$1.1m
CAGR 3-Years
N/A
CAGR 5-Years
2%
CAGR 10-Years
19%
Abbvie Inc
NYSE:ABBV
Interest Income Expense
-$1.8B
CAGR 3-Years
8%
CAGR 5-Years
-7%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Interest Income Expense
-$757m
CAGR 3-Years
35%
CAGR 5-Years
0%
CAGR 10-Years
-10%
Amgen Inc
NASDAQ:AMGN
Interest Income Expense
-$2.9B
CAGR 3-Years
-44%
CAGR 5-Years
-30%
CAGR 10-Years
-16%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Interest Income Expense
$563.1m
CAGR 3-Years
78%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Interest Income Expense
$221.8m
CAGR 3-Years
-13%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is Infinity Pharmaceuticals Inc's Interest Income Expense?
Interest Income Expense
1.1m USD

Based on the financial report for Jun 30, 2023, Infinity Pharmaceuticals Inc's Interest Income Expense amounts to 1.1m USD.

What is Infinity Pharmaceuticals Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
19%